Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination-associated motifs

Human Mutation

Volumn 22, Issue 3, 2003, Pages 229-244

  Abeysinghe, Shaun S ^a   Chuzhanova, Nadia ^a,b   Krawczak, Michael ^c   Ball, Edward V ^a   Cooper, David N ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b SOBOLEV INSTITUTE OF MATHEMATICS   (Russian Federation)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Breakpoint junction sequences; Cancer; Database; Deletion; Gene rearrangement; Inherited disease; Recombination, homologous; Recombination, nonhomologous; Translocation

Indexed keywords

DNA POLYMERASE; IMMUNOGLOBULIN HEAVY CHAIN; NUCLEOTIDE; OLIGONUCLEOTIDE; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SIGNAL PEPTIDE;

ARTICLE; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE DELETION; GENE LOCATION; GENE REARRANGEMENT; GENETIC DATABASE; GENETIC RECOMBINATION; GERM LINE; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN GENOME; MALIGNANT NEOPLASTIC DISEASE; MUTAGENESIS; PRIORITY JOURNAL;

ALU ELEMENTS; BASE COMPOSITION; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENETIC DISEASES, INBORN; GENOME, HUMAN; HUMANS; IMMUNOGLOBULIN JOINING REGION; IMMUNOGLOBULIN VARIABLE REGION; INTERNET; NEOPLASMS; RECOMBINATION, GENETIC; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSLOCATION, GENETIC;

EID: 0043264447     PISSN: 10597794     EISSN: None     Source Type: Journal    
DOI: 10.1002/humu.10254     Document Type: Article

References (190)

1. Adachi M, Tsujimoto Y. 1990. Potential Z-DNA elements surround the breakpoints of chromosome translocation within the 5′ flanking region of bcl-2 gene. Oncogene 5:1653-1657.
2. Amos-Landgraf JM, Ji Y, Gottlieb W, Depinet T Wandstrat AE, Cassidy SB, Driscoll DJ, Rogan PK, Schwartz S, Nicholls RD. 1999. Chromosome breakage in the Prader-Willi and Angelman syndromes involves recombination between large, transcribed repeats at proximal and distal breakpoints. Am J Hum Genet 65:370-386.
3. Aoki K, Nakahara K, Ikegawa C, Seto M, Takahashi T, Minowada J, Strominger JL, Maziarz RT, Kasai M. 1994. Nuclear proteins binding to a novel target sequence within the recombination hotspot regions of Bcl-2 and the immunoglobulin DH gene family. Oncogene 9:1109-1115.
4. Aoki K, Suzuki K, Sugano T, Tasaka T, Nakahara K, Kuge O, Omori A, Kasai M. 1995. A novel gene, translin, encodes a recombination hotspot binding protein associated with chromosomal translocations. Nat Genet 10:167-174.
5. Aplan PD, Lombardi DP, Ginsberg AM, Cossman J, Bertness VL, Kirsch IR. 1990. Disruption of the human SCL locus by "illegitimate" V-(D)-recombinase activity. Science 250:1426-1429.
6. Auer RL, Jones C, Mullenbach RA, Syndercombe-Court D, Milligan DW, Fegan CD, Cotter FE. 2001. Role for CCG-trinucleotide repeats in the pathogenesis of chronic lymphocytic leukemia. Blood 97:509-515.
7. Badge RM, Yardley J, Jeffreys AJ, Armour JA. 2000. Crossover breakpoint mapping identifies a subtelomeric hotspot for male meiotic recombination. Hum Mol Genet 9:1239-1244.
8. Baran N, Lapidot A, Manor H. 1987. Unusual sequence element found at the end of an amplicon. Mol Cell Biol 7:2636-2640.
9. Barr FG. 1998. Translocations, cancer and the puzzle of specificity. Nat Genet 19:121-124.
10. Bassing CH, Swat W, Alt FW. 2002. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109(Suppl):S45-S55.
11. Bechert T, Diekmann S, Arndt-Jovin DJ. 1994. Human 170 kDa and 180 kDa topoisomerases II bind preferentially to curved and left-handed linear DNA. J Biomol Struct Dyn 12:605-623.
12. Been MD, Burgess RR, Champoux JJ. 1984. Nucleotide sequence preference at rat liver and wheat germ type 1 DNA topoisomerase breakage sites in duplex SV40 DNA. Nucleic Acids Res 12:3097-3114.
13. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM. 1996. Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931-13936.
14. Bishop AJR, Schiestl RH. 2000. Homologous recombination as a mechanism for genome rearrangements: environmental and genetic effects. Hum Mol Genet 9:2427-2434.
15. Bishop AJR, Schiestl RH. 2001. Homologous recombination as a mechanism of carcinogenesis. Biochim Biophys Acta 1471:M109-M121.
16. Boehm T, Mengle-Gaw L, Kees UR, Spurr N, Lavenir I, Forster A, Rabbitts TH. 1989. Alternating purine-pyrimidine tracts may promote chromosomal translocations seen in a variety of human lymphoid tumours. EMBO J 8:2621-2631.
17. Boulikas T. 1993. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J Cell Biochem 52:14-22.
18. Breit TM, Mol EJ, Wolvers-Tettero IL, Ludwig WD, van Wering ER, van Dongen JJ. 1993. Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes. J Exp Med 177:965-977.
19. Broeker PL, Super HG, Thirman MJ, Pomykala H, Yonebayashi Y, Tanabe S, Zeleznik-Le N, Rowley JD. 1996. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukaemia and in treatment-related acute myeloid leukaemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites. Blood 87:1912-1922.
20. Bullock P, Miller J, Botchan M. 1986. Effects of poly [d(pGpT).d(pApC)] and poly [d(pCpG).d(pCpG)] repeats on homologous recombination in somatic cells. Mol Cell Biol 6:3948-3953.
21. Cao X, Eu KW, Seow-Choen F, Zhao Y, Cheah PY. 2001. Topoisomerase-I- and Alu-mediated genomic deletions of the APC gene in familial adenomatous polyposis. Hum Genet 108:436-442.
22. Chalk JG, Barr FG, Mitchell CD. 1997. Translin recognition site sequences flank chromosome translocation breakpoints in alveolar rhabdomyosarcoma cell lines. Oncogene 15:1199-1205.
23. Chen X, Mariappan SV, Moyzis RK, Bradbury EM, Gupta G. 1998. Hairpin induced slippage and hyper-methylation of the fragile X DNA triplets. J Biomol Struct Dyn 15:745-756.
24. Chuzhanova N, Abeysinghe SS, Krawczak M, Cooper DN. 2003. Translocation and gross deletion breakpoints in human inherited disease and cancer II. Potential involvement of repetitive elements in secondary structure formation between DNA ends. Hum Mutat 22:245-252.
25. Cohen O, Cans C, Cuillel M, Gilardi JL, Roth H, Mermet MA, Jalbert P, Demongeot J. 1996. Cartographic study: breakpoints in 1574 families carrying human reciprocal translocations. Hum Genet 97:659-667.
26. Cuomo CA, Mundy CL, Oettinger MA. 1996. DNA sequence and structure requirements for cleavage of V(D)J recombination signal sequences. Mol Cell Biol 16:5683-5690.
27. Dallapiccola B, Mingarelli R, Novelli G. 1995. The link between cytogenetics and mendelism. Biomed Pharmacother 49:83-93.
28. Davila M, Foster S, Kelsoe G, Yang K. 2001. A role for secondary V(D)J recombination in oncogenic chromosomal translocations? Adv Cancer Res 81:61-92.
29. Dayn A, Samadashwily GM, Mirkin SM. 1992. Intramolecular DNA triplexes: unusual sequence requirements and influence on DNA polymerization. Proc Natl Acad Sci USA 89:11406-11410.
30. Degan M, Doliana R, Gloghini A, Di Francia R, Aldinucci D, Mazzocut-Zecchin L, Colombatti A, Attadia V, Carbone A, Gattei V. 2002. A novel bcl-1/JH breakpoint from a patient affected by mantle cell lymphoma extends the major translocation cluster. J Pathol 197:256-263.
31. Deininger PL, Batzer MA. 1999. Alu repeats and human disease. Mol Genet Metab 67:183-193.
32. Demura M, Takeda Y, Yoneda T, Furukawa K, Usukura M, Itoh Y, Mabuchi H. 2002. Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. Hum Mutat 19:23-29.
33. Dewyse P, Bradley WE. 1991. A Avery large spontaneous deletion at aprt locus in CHO cells: sequence similarities with small aprt deletions. Somat Cell Mol Genet 17:57-68.
34. Dong S, Geng JP, Tong JH, Wu Y, Cai JR, Sun GL, Chen SR, Wang ZY, Larsen CJ, Berger R, Chen SJ, Chen Z. 1993. Breakpoint clusters of the PML gene in acute promyelocytic leukaemia: primary structure of the reciprocal products of the PML-RARA gene in a patient with t(15;17). Genes Chrom Cancer 6:133-139.
35. Early P, Huang H, Davis M, Calame K, Hood L. 1980. An immunoglobulin heavy chain variable region gene is generated from three segments of DNA: VH, D and JH. Cell 19:981-992.
36. Edelmann L, Pandita RK, Spiteri E, Funke B, Goldberg R, Palanisamy N, Chaganti RS, Magenis E, Shprintzen RJ, Morrow BE. 1999. A common molecular basis for rearrangement disorders on chromosome 22q11. Hum Mol Genet 8:1157-1167.
37. Edelmann L, Spiteri E, Koren K, Pulijaal V, Bialer MG, Shanske A, Goldberg R, Morrow BE. 2001. AT-rich palindromes mediate the constitutional t(11;22) translocation. Am J Hum Genet 68:1-13.
38. Edelmann W, Kroger B, Goller M, Horak I. 1989. A recombination hotspot in the LTR of a mouse retrotransposon identified in an in vitro system. Cell 57:937-946.
39. Eguchi M, Eguchi-Ishimae M, Seto M, Morishita K, Suzuki K, Ueda R, Ueda K, Kamada N, Greaves M. 2001. GPHN, a novel partner gene fused to MLL in a leukaemia with t(11;14) (q23;q24). Genes Chrom Cancer 32:212-221.
40. Eisenbarth I, Vogel G, Krone W, Vogel W, Assum G. 2000. An isochore transition in the NF1 gene region coincides with a switch in the extent of linkage disequilibrium. Am J Hum Genet 67:873-880.
41. Elliot B, Jasin M. 2002. Double strand breaks and translocations in cancer. Cell Mol Life Sci 59:373-385.
42. Ellison MJ, Feigon J, Kelleher RJ 3rd, Wang AH, Habener JF, Rich A. 1986. An assessment of the Z-DNA forming potential of alternating dA-dT stretches in supercoiled plasmids. Biochemistry 25:3648-3655.
43. Felix CA, Lange BJ, Hosler MR, Fertala J, Bjornsti MA. 1995. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 55:4287-4292.
44. Fenton JA, Vaandrager JW, Aarts WM, Bende RJ, Heering K, van Dijk M, Morgan G, van Noesel CJ, Schuuring E, Kluin PM. 2002. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells. Blood 99:716-718.
45. Frank-Kamenetskii MD, Mirkin SM. 1995. Triplex DNA structures. Annu Rev Biochem 64:65-95.
46. Fuscoe JC, Zimmerman LJ, Lippert MJ, Nicklas JA, O'Neill JP, Albertini RJ. 1991. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res 51:6001-6005.
47. Fuscoe JC, Zimmerman LJ, Harrington-Brock K, Burnette L, Moore MM, Nicklas JA, O'Neill JP, Albertini RJ. 1992. V(D)J recombinase-mediated deletion of the hprt gene in T-lymphocytes from adult humans. Mutat Res 283:13-20.
48. Garcia IS, Kaneko Y, Gonzalez-Sarmiento R, Campbell K, White L, Boehm T, Rabbitts TH. 1991. A study of chromosome 11p13 translocations involving TCR beta and TCR delta in human T cell leukaemia. Oncogene 6:577-582.
49. Garner MM, Felsenfeld G. 1987. Effect of Z-DNA on nucleosome placement. J Mol Biol 196:581-590.
50. Gerstein RM, Frankel WN, Hsieh CL, Durdik JM, Rath S, Coffin JM, Nisonoff A, Selsing E. 1990. Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes. Cell 63:537-548.
51. Haber JE. 2000. Partners and pathways: repairing a double strand break. Trends Genet 16:259-264.
52. Hampel KJ, Ashley C, Lee JS. 1994. Kilobase-range communication between polypurine polypyrimidine tracts in linear plasmids mediated by triplex formation: a braided knot between two linear duplexes. Biochemistry 33:5674-5681.
53. Haniford DB, Pulleyblank DE. 1983. Facile transition of poly[d(TG) × d(CA)] into a left-handed helix in physiological conditions. Nature 302:632-634.
54. Harteveld KL, Losekoot M, Fodde R, Giordano PC, Bernini LF. 1997. The involvement of Alu repeats in recombination events at the α-globin gene cluster: characterization of two α°-thalassaemia deletion breakpoints. Hum Genet 99:528-534.
55. Hensel JP, Gillert E, Fey GH, Marschalek R. 2001. Breakpoints of t(4;11) translocations in the MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions. J Cell Biochem 82:299-309.
56. Herbert A, Rich A. 1996. The biology of left-handed Z-DNA. J Biol Chem 271:11595-11598.
57. Herbert A, Rich A. 1999. Left-handed Z-DNA: structure and function. Genetica 106:37-47.
58. Hirai H, Ogawa S, Kurokawa M, Yazaki Y, Mitani K. 1999. Molecular characterization of the genomic breakpoints in a case of t(3;21)(q26;q22). Genes Chrom Cancer 26:92-96.
59. Ho PJ, Brown RD, Pelka GJ, Basten A, Gibson J, Joshua DE. 2001. Illegitimate switch recombinations are present in approximately half of primary myeloma tumors, but do not relate to known prognostic indicators or survival. Blood 97:490-495.
60. Hogan A, Faust EA. 1986. Nonhomologous recombination in the parvovirus chromosome: role for a CTATTTCT motif. Mol Cell Biol 6:3005-3009.
61. Hosaka T, Kanoe H, Nakayama T, Murakami H, Yamamoto H, Nakamata T, Tsuboyama T, Oka M, Kasai M, Sasaki MS, Nakamura T, Toguchida J. 2000. Translin binds to the sequences adjacent to the breakpoints in the TLS and CHOP genes in liposarcomas with translocation t(12;6). Oncogene 19:5821-5825.
62. Hyrien O. 2000. Mechanisms and consequences of replication fork arrest. Biochimie 82:5-17.
63. Jaeger U, Purtscher B, Karth GD, Knapp S, Mannhalter C, Lechner K. 1993. Mechanism of the chromosomal translocation t(14;18) in lymphoma: detection of a 45-Kd breakpoint binding protein. Blood 81:1833-1840.
64. Jager U, Bocskor S, Le T, Mitterbauer G, Bolz I, Chott A, Kneba M, Mannhalter C, Nadel B. 2000. Follicular lymphomas' BCL-2/IgH junctions contain templated nucleotide insertions: novel insights into the mechanism of t(14;18) translocation. Blood 95:3520-3529.
65. Janssen JW, Ludwig WD, Sterry W, Bartram CR. 1993. SIL-TAL1 deletion in T-cell acute lymphoblastic leukemia. Leukemia 7:1204-1210.
66. Jeffreys AJ, Wilson V, Thein SL. 1985. Hypervariable " minisatellite" regions in human DNA. Nature 314:67-73.
67. Jeffs AR, Benjes SM, Smith TL, Sowerby SJ, Morris CM. 1998. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet 7:767-776.
68. Ji Y, Eichler EE, Schwartz S, Nicholls RD. 2000. Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 10:597-610.
69. Jin P, Warren ST. 2000. Understanding the molecular basis of fragile X syndrome. Hum Mol Genet 9:901-908.
70. Jones C, Mullenbach R, Grossfeld P, Auer R, Favier R, Chien K, James M, Tunnacliffe A, Cotter F. 2000. Co-localisation of CCG repeats and chromosome deletion breakpoints in Jacobsen syndrome: evidence for a common mechanism of chromosome breakage. Hum Mol Genet 9:1201-1208.
71. Kang S, Ohshima K, Shimizu M, Amirhaeri S, Wells RD. 1995. Pausing of DNA synthesis in vitro at specific loci in CTG and CGG triplet repeats from human hereditary disease genes. J Biol Chem 270:27014-27021.
72. Kanoe H, Nakayama T, Hosaka T, Murakami H, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Ron D, Sasaki MS, Toguchida J. 1999. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of translin and topoisomerase II in the process of translocation. Oncogene 18:721-729.
73. Kariya Y, Kato K, Hayashizaki Y, Himeno S, Tarui S, Matsubara K. 1987. Revision of consensus sequence of human Alu repeats: a review. Gene 53:1-10.
74. Karsten SL, Lagerstedt K, Carlberg BM, Kleijer WJ, Zaremba J, Van Diggelen OP, Czartoryska B, Pettersson U, Bondeson ML. 1997. Two distinct deletions in the IDS gene and the gene W: a novel type of mutation associated with the Hunter syndrome. Genomics 43:123-129.
75. Kasai M, Aoki K, Matsuo Y, Minowada J, Maziarz RT, Strominger JL. 1994. Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8;14)(q24;q11) and t(1;14)(p32;q11). Int Immunol 6:1017-1025.
76. Kasai M, Matsuzaki T, Katayanagi K, Omori A, Maziarz RT, Strominger JL, Aoki K, Suzuki K. 1997. The translin ring specifically recognizes DNA ends at recombination hot spots in the human genome. J Biol Chem 272:11402-11407.
77. Kataoka T, Kawakami T, Takahashi N, Honjo T. 1980. Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch. Proc Natl Acad Sci USA 77:919-923.
78. Kato S, Tachibana K, Takayama N, Kataoka H, Yoshida MC, Takano T. 1991. Genetic recombination in a chromosomal translocation t(2;8)(p11;q24) of a Burkitt's lymphoma cell line, KOBK101. Gene 97:239-244.
79. Kehrer-Sawatzki H, Haussler J, Krone W, Bode H, Jenne DE, Mehnert KU, Tummers U, Assum G. 1997. The second case of a t(17;22) in a family with neurofibromatosis type 1: sequence analysis of the breakpoint regions. Hum Genet 99:237-247.
80. Kinoshita K, Tashiro J, Tomita S, Lee CG, Honjo T. 1998. Target specificity of immunoglobulin class switch recombination is not determined by nucleotide sequences of S regions. Immunity 9:849-858.
81. Kitagawa Y, Inoue K, Sasaki S, Hayashi Y, Matsuo Y, Lieber MR, Mizoguchi H, Yokota J, Kohno T. 2002. Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukaemia. J Biol Chem 277:46289-46297.
82. Kleinfeld R, Hardy RR, Tarlinton D, Dangl J, Herzenberg LA, Weigert M. 1986. Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1 + B-cell lymphoma. Nature 322:843-846.
83. Knapp S, Delle Kart G, Friedl J. 1994. Guanine-rich (GGNNGG) elements at chromosomal breakpoints interact with a loop-forming, single-stranded DNA-binding protein. Oncogene 9:1501-1505.
84. Kolomietz E, Meyn MS, Pandita A, Squire JA. 2002. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chrom Cancer 35:97-112.
85. Kowalczykowski SC, Dixon DA, Eggleston AK, Lauder SD, Rehrauer WM. 1994. Biochemistry of homologous recombination in Escherichia coli. Microbiol Rev 58:401-465.
86. Kowalczykowski SC. 2000. Initiation of genetic recombination and recombination-dependent replication. Trends Biochem Sci 25:156-165.
87. Kozubek S, Lukásová E, Jirsová P, Koutna I, Kozubek M, Ganova A, Bartova E, Falk M, Pasekova R. 2002. 3D structure of the human genome: order in randomness. Chromosoma 111:321-331.
88. Krawczak M, Cooper DN. 1991. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet 86:425-441.
89. Krowczynska AM, Rudders RA, Krontiris TG. 1990. The human minisatellite consensus at breakpoints of oncogene translocations. Nucleic Acids Res 18:1121-1127.
90. Kunkel TA. 1985a. The mutational specificity of DNA polymerase-beta during in vitro DNA synthesis. Production of frame-shift, base substitution, and deletion mutations. J Biol Chem 260:5787-5796.
91. Kunkel TA. 1985b. The mutational specificity of DNA polymerases-alpha and -gamma during in vitro DNA synthesis. J Biol Chem 260:12866-12874.
92. Kurahashi H, Emanuel BS. 2001. Long AT-rich palindromes and the constitutional t(11;22) breakpoint. Hum Mol Genet 10:2605-2617.
93. Lapidot A, Baran N, Manor H. 1989. (dT-dC)n and (dG-dA)n tracts arrest single stranded DNA replication in vitro. Nucleic Acids Res 17:883-900.
94. Lee GS, Neiditch MB, Sinden RR, Roth DB. 2002. Targeted transposition by the V(D)J recombinase. Mol Cell Biol 22:2068-2077.
95. Lee JS, Asley C, Hampel KJ, Bradley R, Scraba DG. 1995. A stable interaction between separated pyrimidine-purine tracts in circular DNA. J Mol Biol 252:283-288.
96. Liu LF, Wang JC. 1987. Supercoiling of the DNA template during transcription. Proc Natl Acad Sci USA 84:7024-7027.
97. Longa L, Saluto A, Brusco A, Polidoro S, Padovan S, Allavena A, Carbonara C, Grosso E, Migone N. 2001. TSC1 and TSC2 deletions differ in size, preference for recombinatorial sequences, and location within the gene. Hum Genet 108:156-166.
98. Lopez-Correa C, Dorschner M, Brems H, Lazaro C, Clementi M, Upadhyaya M, Dooijes D, Moog U, Kehrer-Sawatzki H, Rutkowski JL, Fryns JP, Marynen P, Stephens K, Legius E. 2001. Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet 10:1387-1392.
99. Lovett BD, Lo Nigro L, Rappaport EF, Blair IA, Osheroff N, Zheng N, Megonigal MD, Williams WR, Nowell PC, Felix CA. 2001. Near-precise interchromosomal recombination and function of DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukaemia with t(4;11) translocation. Proc Natl Acad Sci USA 98:9802-9807.
100. Lu M, Dube I, Raimondi S, Carroll A, Zhao Y, Minden M, Sutherland P. 1990. Molecular characterization of the t(10;14) translocation breakpoints in T-cell acute lymphoblastic leukaemia: further evidence for illegitimate physiological recombination. Genes Chrom Cancer 2:217-222.
101. Lu M, Zhang N, Raimondi S, Ho AD. 1992. S1 nuclease hypersensitive sites in an oligopurine/oligopyrimidine DNA from the t(10;14) breakpoint cluster region. Nucleic Acids Res 20:263-266.
102. Lupski JR. 1998. Genomic disorders: structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet 14:417-422.
103. Lyamichev VI, Mirkin SM, Frank-Kamenetskii MD. 1985. A pH-dependent structural transition in the homopurine-homopyrimidine tract in superhelical DNA. J Biomol Struct Dyn 3:327-338.
104. Lyamichev VI, Mirkin SM, Frank-Kamenetskii MD. 1986. Structures of homopurine-homopyrimidine tract in superhelical DNA. J Biomol Struct Dyn 3:667-669.
105. McGuire EA, Hockett RD, Pollock KM, Bartholdi MF, O'Brien SJ, Korsmeyer SJ. 1989. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukaemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein. Mol Cell Biol 9:2124-2132.
106. McNaughton JC, Cockburn DJ, Hughes G, Jones WA, Laing NG, Ray PN, Stockwell PA, Petersen GB. 1998. Is gene deletion in eukaryotes sequence-dependent? A study of nine deletion junctions and nineteen other deletion breakpoints in intron 7 of the human dystrophin gene. Gene 222:41-51.
107. Majewski J, Ott J. 2000. GT repeats are associated with recombination on human chromosome 22. Genome Res 10:1108-1114.
108. Marculescu R, Le T Simon P, Jaeger U, Nadel B. 2002. V(D)J-mediated translocations in lymphoid neoplasms: a functional assessment of genomic instability by cryptic sites. J Exp Med 195:85-98.
109. Mercher T, Busson-Le Coniat M, Khac FN, Ballerini P, Mauchauffe M, Bui H, Pellegrino B, Radford I, Valensi F, Mugneret F, Dastugue N, Bernard OA, Berger R. 2002. Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7. Genes Chrom Cancer 33:22-28.
110. Michel B. 2000. Replication fork arrest and DNA recombination. Trends Biochem Sci 25:173-178.
111. Milot E, Belmaaza A, Wallenburg JC, Gusew N, Bradley WE, Chartrand P. 1992. Chromosomal illegitimate recombination in mammalian cells is associated with intrinsically bent DNA elements. EMBO J 11:5063-5070.
112. Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM. 1999. Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci USA 96:7456-7461.
113. Mirkin SM, Lyamichev VI, Drushlyak KN, Dobrynin VN, Filippov SA, Frank-Kamenetskii MD. 1987. DNA H form requires a homopurine-homopyrimidine mirror repeat. Nature 330:495-497.
114. Mitelman F, Mertens F, Johansson B. 1997. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet (Suppl):417-430.
115. Mitelman F. 2000. Recurrent chromosome aberrations in cancer. Mutat Res 462:247-253.
116. Monnat RJ Jr, Hackmann AF, Chiaverotti TA. 1992. Nucleotide sequence analysis of human hypoxanthine phosphoribosyltransferase (HPRT) gene deletions. Genomics 13:777-787.
117. Nagele R, Freeman T, McMorrow L, Lee H-Y. 1995. Precise spatial positioning of chromosomes during prometaphase: evidence for chromosomal order. Science 270:1831-1834.
118. Nagele RG, Freeman T, McMorrow L, Thomson Z, Kitson-Wind K, Lee H. 1999. Chromosomes exhibit preferential positioning in nuclei of quiescent human cells. J Cell Sci 112:525-535.
119. Neves H, Ramos C, da Silva MG, Parreira A, Parreira L. 1999. The nuclear topography of ABL, BCR, PML, and RAR alpha genes: evidence for gene proximity in specific phases of the cell cycle and stages of hematopoietic differentiation. Blood 93:1197-1207.
120. Nobile C, Toffolatti L, Rizzi F, Simionati B, Nigro V, Cardazzo B, Patarnello T, Valle G, Danieli GA. 2002. Analysis of 22 deletion breakpoints in dystrophin intron 49. Hum Genet 110:418-421.
121. Obata K, Hiraga H, Nojima T, Yoshida MC, Abe S. 1999. Molecular characterization of the genomic breakpoint junction in a t(11;22) translocation in Ewing sarcoma. Genes Chrom Cancer 25:6-15.
122. Ohno S. 1981. (AGCTG) (AGCTG) (AGCTG) (GGGTG) as the primordial sequence of intergenic spacers: the role in immunoglobulin class switch. Differentiation 18:65-74.
123. Onno M, Nakamura T, Hillova J, Hill M. 1992. Rearrangement of the human tre oncogene by homologous recombination between Alu repeats of nucleotide sequences from two different chromosomes. Oncogene 7:2519-2523.
124. Osterholm AM, Bastlova T, Meijer A, Podlutsky A, Zanesi N, Hou SM. 1996. Sequence analysis of deletion mutations at the HPRT locus of human T-lymphocytes: association of a palindromic structure with a breakpoint cluster in exon 2. Mutagenesis 11:511-517.
125. Otto E, Betz R, Rensing C, Schatzle S, Kuntzen T, Vetsi T, Imm A, Hildebrandt F. 2000. A deletion distinct from the classical recombination of juvenile nephronophthisis type 1 (NPH1) allows exact molecular definition of deletion breakpoints. Hum Mutat 16:211-223.
126. Panagopoulos I, Lassen C, Isaksson M, Mitelman F, Mandahl N, Aman P. 1997. Characteristic sequence motifs at the breakpoints of the hybrid genes FUS/CHOP, EWS/CHOP and FUS/ERG in myxoid liposarcoma and acute myeloid leukemia. Oncogene 15:1357-1362.
127. Panagopoulos I, Isaksson M, Lindvall C, Hagemeijer A, Mitelman F, Johansson B. 2003. Genomic characterization of MOZ/CBP and CBP/MOZ chimeras in acute myeloid leukaemia suggests the involvement of a damage-repair mechanism in the origin of the t(8;16)(p11;p13). Genes Chrom Cancer 36:90-98.
128. Peck LJ, Wang JC. 1985. Transcriptional block caused by a negative supercoiling induced structural change in an alternating CG sequence. Cell 40:129-137.
129. Petes TD. 2001. Meiotic recombination hot spots and cold spots. Nat Rev Genet 2:360-369.
130. Pfeiffer P, Thode S, Hancke J, Vielmetter W. 1994. Mechanisms of overlap formation in nonhomologous DNA end joining. Mol Cell Biol 14:888-895.
131. Pfeiffer P, Goedecke W, Obe G. 2000. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis 15:289-302.
132. Pomponio RJ, Narasimhan V, Reynolds TR, Buck GA, Povirik LF, Wolf B. 1996. Deletion/insertion mutation that causes biotinidase deficiency may result from the formation of a quasipalindromic structure. Hum Mol Genet 5:1657-1661.
133. Pomykala HM, Bohlander SK, Broeker PL, Olopade OI, Diaz MO. 1994. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol Cell Biol 14:7604-7610.
134. Purandare SM, Patel PI. 1997. Recombination hot spots and human disease. Genome Res 7:773-786.
135. Rabbitts TH, Forster A, Milstein CP. 1981. Human immunoglobulin heavy chain genes: evolutionary comparisons of C mu, C delta and C gamma genes and associated switch sequences. Nucleic Acids Res 9:4509-4524.
136. Rabbitts TH. 1994. Chromosomal translocations in human cancer. Nature 372:143-149.
137. Raghavan SC, Kirsch IR, Lieber MR. 2001. Analysis of the V(D)J recombination efficiency at lymphoid chromosomal translocation breakpoints. J Biol Chem 276:29126-29133.
138. Ramakrishnan M, Liu WM, DiCroce PA, Posner A, Zheng J, Kohwi-Shigematsu T, Krontiris TG. 2000. Modulated binding of SATB1, a matrix attachment region protein, to the AT-rich sequence flanking the major breakpoint region of BCL2. Mol Cell Biol 20:868-877.
139. Ramsden DA, McBlane JF, van Gent DC, Gellert M. 1996. Distinct DNA sequence and structure requirements for the two steps of V(D)J recombination signal cleavage. EMBO J 15:3197-3206.
140. Reiter LT, Murakami T, Koeuth T, Pentao L, Muzny DM, Gibbs RA, Lupski JR. 1996. A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet 12:288-297.
141. Reth MG, Jackson S, Alt FW. 1986. VHDJH formation and DJH replacement during pre-B differentiation: non-random usage of gene segments. EMBO J 5:2131-2138.
142. Richardson C, Jasin M. 2000. Coupled homologous and non-homologous repair of a double strand break preserves genomic integrity in mammalian cells. Mol Cell Biol 20:9068-9075.
143. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A. 1997. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90:4062-4070.
144. Rooney SM, Moore PD. 1995. Antiparallel, intramolecular triplex DNA stimulates homologous recombination in human cells. Proc Natl Acad Sci USA 92:2141-2144.
145. Rüdiger NS, Gregersen N, Kielland-Brandt MC. 1995. One short well conserved region of Alu-sequences is involved in human gene rearrangements and has homology with prokaryotic chi. Nucleic Acids Res 23:256-260.
146. Sánchez-García I. 1997. Consequences of chromosomal abnormalities in tumor development. Annu Rev Genet 31:429-453.
147. Sander M, Hsieh TS. 1985. Drosophila topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site. Nucleic Acids Res 13:1057-1072.
148. Sargent RG, Brenneman MA, Wilson JH. 1997. Repair of site-specific double-strand breaks in a mammalian chromosome by homologous and illegitimate recombination. Mol Cell Biol 17:267-277.
149. Sato Y, Akiyama Y, Tanizawa T, Shibata T, Saito K, Mori S, Kamiyama R, Yuasa Y. 2001. Molecular characterization of the genomic breakpoint junction in the t(11;18) (q21;q21) translocation of a gastric MALT lymphoma. Biochem Biophys Res Commun 280:301-306.
150. Schmidt HH. 2002. Multiple myeloma: illegitimate switch recombinations and their relation to chromosomal translocations. Blood 99:3072-3073.
151. Schmucker B, Ballhausen WG, Pfeiffer RA. 1996. Mosaicism of a microdeletion of 486 bp involving the CGG repeat of the FMR1 gene due to misalignment of GTT tandem repeats at chi-like elements flanking both breakpoints and a full mutation. Hum Genet 98:409-414.
152. Schroth GP, Chou PJ, HO PS. 1992. Mapping Z-DNA in the human genome. Computer-aided mapping reveals a non-random distribution of Z-DNA-forming sequences in human genes. J Biol Chem 267:11846-11855.
153. Sengupta K, Rao BJ. 2002. Translin binding to DNA: recruitment through DNA ends and consequent conformational transitions. Biochemistry 41:15315-15326.
154. Shimizu A, Honjo T. 1984. Immunoglobulin class switching. Cell 36:801-803.
155. Showe LC, Ballantine M, Nishikura K, Erikson J, Kaji H, Croce CM. 1985. Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol 5:501-509.
156. Shuman S. 1991. Site-specific DNA cleavage by vaccinia virus DNA topoisomerase I. Role of nucleotide sequence and DNA secondary structure. J Biol Chem 266:1796-1803.
157. Singleton CK, Klysik J, Stirdivant SM, Wells RD. 1982. Left-handed Z-DNA is induced by supercoiling in physiological ionic conditions. Nature 299:312-316.
158. Slater DJ, Hilgenfeld E, Rappaport EF, Shah N, Meek RG, Williams WR, Lovett BD, Osheroff N, Autar RS, Ried T, Felix CA. 2002. MLL-SEPTIN6 fusion recurs in a novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X:11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomerase II cleavage site. Oncogene 21:4706-4714.
159. Smith GR. 1983. Chi hotspots of generalized recombination. Cell 34:709-710.
160. Spitzner JR, Chung IK, Muller MT 1990. Eukaryotic topoisomerase II preferentially cleaves alternating purine-pyrimidine repeats. Nucleic Acids Res 18:1-11.
161. Spitzner JR, Muller MT 1988. A consensus sequence for cleavage by vertebrate DNA topoisomerase II. Nucleic Acids Res 16:5533-5556.
162. Stamatopoulos K, Kosmas C, Belessi C, Kyriazopoulos P, Papadaki T, Anagnostou D, Loukopoulos D. 1999. Molecular analysis of bcl-1/IgH junctional sequences in mantle cell lymphoma: potential mechanism of the t(11;14) chromosomal translocation. Br J Haematol 105:190-197.
163. Stankiewicz P, Lupski JR. 2002. Genome architecture, rearrangements and genomic disorders. Trends Genet 18:74-82.
164. Stary A, Sarasin A. 1992. Molecular analysis of DNA junctions produced by illegitimate recombination in human cells. Nucleic Acids Res 20:4269-4274.
165. Steinmetz M, Stephan D, Fischer LK. 1986. Gene organization and recombinational hotspots in the murine major histocompatibility complex. Cell 44:895-904.
166. Steinmetz M, Vematsu Y, Lindahl KF. 1987. Hotspots of homologous recombination in mammalian genomes. Trends Genet 3:7-10.
167. Strissel PL, Dann HA, Pomykala HM, Diaz MO, Rowley JD, Olopade OI. 1998. Scaffold-associated regions in the human type I interferon gene cluster on the short arm of chromosome 9. Genomics 47:217-229.
168. Strissel PL, Strick R, Tomek RJ, Roe BA, Rowley JD, Zeleznik-Le NJ. 2000. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum Mol Genet 9:1671-1679.
169. Tashiro J, Kinoshita K, Honjo T 2001. Palindromic but not G-rich sequences are targets of class switch recombination. Int Immunol 13:495-505.
170. Tashiro S, Kotomura N, Tanaka K, Suzuki K, Kyo T, Dohy H, Niwa O, Kamada N. 1994. Identification of illegitimate recombination hot spot of the retinoic acid receptor alpha gene involved in 15;17 chromosomal translocation of acute promyelocytic leukaemia. Oncogene 9:1939-1945.
171. Thandla SP, Ploski JE, Raza-Egilmez SZ, Chhalliyil PP, Block AW, deJong PJ, Aplan PD. 1999. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93:293-299.
172. Tsujimoto Y, Bashir MM, Givol I, Cossman J, Jaffe E, Croce CM. 1987. DNA rearrangements in human follicular lymphoma can involve the 5′ or the 3′ region of the bcl-2 gene. Proc Natl Acad Sci USA 84:1329-1331.
173. Ueki Y, Naito I, Oohashi T, Sugimoto M, Seki T, Yoshioka H, Sado Y, Sato H, Sawai T, Sasaki F, Matsuoka M, Fukuda S, Ninomiya Y. 1998. Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated with Alport syndrome. Am J Hum Genet 62:253-261.
174. Usuda S, Takemori T, Matsuoka M, Shirasawa T, Yoshida K, Mori A, Ishizaka K, Sakano H. 1992. Immunoglobulin V gene replacement is caused by the intramolecular DNA deletion mechanism. EMBO J 11:611-618.
175. Vaandrager JW, Schuuring E, Philippo K, Kluin PM. 2000. V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma. Blood 96:1947-1952.
176. van Gent DC, Hoeijmakers JHJ, Kanaar R. 2001. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2:196-206.
177. Viguera E, Canceill D, Ehrlich SD. 2001. Replication slippage involves DNA polymerase pausing and dissociation. EMBO J 20:2587-2595.
178. von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G. 1992. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukaemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukaemia. Genes Chrom Cancer 5:227-234.
179. Wahls WP, Wallace LJ, Moore PD. 1990a. Hypervariable minisatellite DNA is a hotspot for homologous recombination in human cells. Cell 60:95-103.
180. Wahls WP, Wallace LJ, Moore PD. 1990b. The Z-DNA motif d(TG)30 promotes reception of information during gene conversion events while stimulating homologous recombination in human cells in culture. Mol Cell Biol 10:785-793.
181. Weaver DT, DePamphilis ML. 1982. Specific sequences in native DNA that arrest synthesis by DNA polymerase alpha. J Biol Chem 257:2075-2086.
182. Weaver DT, DePamphilis ML. 1984. The role of palindromic and non-palindromic sequences in arresting DNA synthesis in vitro and in vivo. J Mol Biol 180:961-986.
183. Wei Y, Sun M, Wang J, Hou Y, Zhu X. 2002. Sequence analysis of translocation t(X;18) genomic breakpoints charcaterized in synovial sarcoma. Zhonghua Bing Li Xue Za Zhi 31:411-415.
184. Weinreb A, Katzenberg DR, Gilmore GL, Birshtein BK. 1988. Site of unequal sister chromatid exchange contains a potential Z-DNA-forming tract. Proc Natl Acad Sci USA 85:529-533.
185. Wyatt RT, Rudders RA, Zelenetz A, Delellis RA, Krontiris TG. 1992. BCL2 oncogene translocation is mediated by a X-like consensus. J Exp Med 175:1575-1588.
186. Ye BH, Chaganti S, Chang CC, Niu H, Corradini P, Chaganti RS, Dalla-Favera R. 1995. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14:6209-6217.
187. Yu A, Zhao C, Fan Y, Jang W, Mungall AJ, Deloukas P, Olsen A, Doggett NA, Ghebranious N, Broman KW, Weber JL. 2001. Comparison of human genetic and sequence-based physical maps. Nature 409:951-953.
188. Zhang K. 2000. Immunoglobulin class switch recombination machinery: progress and challenges. Clin Immunol 95:1-8.
189. Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau MM, Larson RA, Rowley JD. 2002. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNaseI hypersensitive sites in t(8;21) leukaemia. Proc Natl Acad Sci USA 99:3070-3075.
190. Zucman-Rossi J, Legoix P, Victor J-M, Lopez B, Thomas G. 1998. Chromosome translocation based on illegitimate recombination in human tumors. Proc Natl Acad Sci USA 95:11786-11791.